We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Comparing organ-specific immune-related adverse events for immune checkpoint inhibitors: A Bayesian network meta-analysis.
- Authors
Meichen Li; Xue Hou; Jing Chen; Juan Yu; Meiting Chen; Na Wang; Baishen Zhang; Likun Chen
- Abstract
Received:16November2020 Revised:3January2021 Accepted:4January2021 Publishedonline:20January2021 DOI:10.1002/ctm2.291 LETTER TO EDITOR Comparingorgan-specificimmune-relatedadverseevents forimmunecheckpointinhibitors:ABayesiannetwork meta-analysis DearEditor, Immune checkpoint inhibitor (ICI) drugs have been widelyusedinclinicalpracticeandhavebecomethefirstlinetreatmentregimenforcertaintumors,withICIcombinationtherapiesbeingutilizedparticularlyfrequently. Thedatawererearrangedandmergedtoformthecategories of ICI monotherapy, one ICI drug combined with traditional therapy, two ICI drugs, and traditional therapy.
- Subjects
DRUG side effects; IPILIMUMAB; IMMUNE checkpoint inhibitors; META-analysis
- Publication
Clinical & Translational Medicine, 2021, Vol 11, Issue 2, p1
- ISSN
2001-1326
- Publication type
Article
- DOI
10.1002/ctm2.291